Literature DB >> 30458333

Cognitive functions in young adults with generalized anxiety disorder.

Kiara Leonard1, Amitai Abramovitch2.   

Abstract

BACKGROUND: Anxiety and worry are central symptoms of Generalized Anxiety Disorder (GAD) that have been theorized to negatively impact cognitive functions. However, most of the research has focused on threat-related or emotionally-charged stimuli, and a surprisingly small number of investigations examined 'cold' cognitive functions using classic neuropsychological tests. Such investigations are particularly important given that some theoretical models suggest compensatory mechanisms associated with anxiety that in certain circumstances may result in intact performance. The aim of the present study is to assess the neuropsychological profile associated with GAD, using a comprehensive neuropsychological battery.
METHODS: A sample of 23 college students meeting criteria for DSM-5 GAD and 20 control participants completed a psychometrically valid comprehensive computerized neuropsychological battery and clinical questionnaires.
RESULTS: The GAD sample presented with significantly elevated symptomatic rates of anxiety, worry, depression and stress. However, no significant differences were found on any neuropsychological outcome measures or domain indexes. Effect sizes were small, some of which favored the GAD sample.
CONCLUSION: Despite substantial psychopathological burden, GAD exhibited intact cognitive functioning. These results support the Cognitive Control Theory of Anxiety, suggesting that elevated primary anxiety may not impact 'cold' cognitive functions in the absence of threat or substantial cognitive load. Given that this is one of the only studies employing a comprehensive neuropsychological battery in GAD, more research is needed in this population to replicate these results and to examine the impact of anxiety on cognitive functions at varying degrees of cognitive load in this population.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anxiety; Executive function; GAD; Neuropsychology; Worry

Mesh:

Year:  2018        PMID: 30458333     DOI: 10.1016/j.eurpsy.2018.10.008

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  7 in total

1.  Cognitive Intelligence Assisted Fog-Cloud Architecture for Generalized Anxiety Disorder (GAD) Prediction.

Authors:  Ankush Manocha; Ramandeep Singh; Munish Bhatia
Journal:  J Med Syst       Date:  2019-11-29       Impact factor: 4.460

2.  Cognitive flexibility and response inhibition in patients with Obsessive-Compulsive Disorder and Generalized Anxiety Disorder.

Authors:  Ángel Rosa-Alcázar; Pablo J Olivares-Olivares; Inmaculada Concepción Martínez-Esparza; José Luis Parada-Navas; Ana I Rosa-Alcázar; José Olivares-Rodríguez
Journal:  Int J Clin Health Psychol       Date:  2019-12-31

3.  Quantitative Electroencephalography (QEEG) as an Innovative Diagnostic Tool in Mental Disorders.

Authors:  Marta Kopańska; Danuta Ochojska; Agnieszka Dejnowicz-Velitchkov; Agnieszka Banaś-Ząbczyk
Journal:  Int J Environ Res Public Health       Date:  2022-02-21       Impact factor: 3.390

4.  Increased Intra-Individual Variability as a Marker of Executive Dysfunction in Generalized Anxiety Disorder.

Authors:  Yongju Yu; Haiyan Xu; Yuanyuan Xu; Fang Lu; Min Li
Journal:  Front Psychiatry       Date:  2022-03-22       Impact factor: 4.157

5.  The Role of Physical Activity in the Reduction of Generalised Anxiety Disorder in Young Adults in the Context of COVID-19 Pandemic.

Authors:  Ewelina Czenczek-Lewandowska; Justyna Leszczak; Justyna Wyszyńska; Joanna Baran; Aneta Weres; Bogumił Lewandowski
Journal:  Int J Environ Res Public Health       Date:  2022-09-05       Impact factor: 4.614

6.  Within-person increase in pathological worry predicts future depletion of unique executive functioning domains.

Authors:  Nur Hani Zainal; Michelle G Newman
Journal:  Psychol Med       Date:  2020-03-19       Impact factor: 7.723

7.  Post-COVID-19 conditions in Ecuadorian patients: an observational study.

Authors:  Fabricio González-Andrade
Journal:  Lancet Reg Health Am       Date:  2021-10-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.